VM (nerve agent): Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
== VM ( | == VM (Nerve Agent) == | ||
[[File:VM-2D-skeletal.png|thumb| | [[File:VM-2D-skeletal.png|thumb|right|200px|Skeletal structure of VM nerve agent]] | ||
'''VM''' is a [[nerve agent]] | '''VM''' is a [[nerve agent]] belonging to the [[V-series nerve agents]], which are a group of highly toxic chemical warfare agents. These agents are known for their ability to disrupt the normal functioning of the [[nervous system]] by inhibiting the enzyme [[acetylcholinesterase]]. | ||
== Chemical Properties == | === Chemical Structure and Properties === | ||
VM is | VM is an organophosphorus compound, characterized by its phosphorus-sulfur bond. The skeletal structure of VM is depicted in the image to the right. Like other V-series agents, VM is a [[liquid]] at room temperature and is known for its high [[boiling point]] and low [[volatility]], making it a persistent threat in contaminated environments. | ||
== Mechanism of Action == | === Mechanism of Action === | ||
VM, like other nerve agents, exerts its toxic effects by inhibiting the enzyme acetylcholinesterase. This enzyme is crucial for the breakdown of the neurotransmitter [[acetylcholine]] in the [[synaptic cleft]]. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to continuous stimulation of [[muscles]], [[glands]], and [[central nervous system]] structures. This results in a range of symptoms, including [[muscle twitching]], [[respiratory failure]], and potentially [[death]]. | |||
== Symptoms of Exposure == | === Symptoms of Exposure === | ||
Exposure to VM can | Exposure to VM can lead to a variety of symptoms, depending on the dose and route of exposure. Common symptoms include: | ||
* [[Miosis]] (constriction of the pupils) | |||
* [[Rhinorrhea]] (runny nose) | |||
* [[Bronchoconstriction]] | |||
* [[Muscle weakness]] | |||
* [[Seizures]] | |||
* [[Coma]] | |||
== Treatment == | === Treatment === | ||
The primary treatment for VM exposure | The primary treatment for VM exposure involves the administration of [[atropine]] and [[pralidoxime]]. Atropine works by blocking the effects of acetylcholine at muscarinic receptors, while pralidoxime reactivates acetylcholinesterase by removing the phosphate group attached by the nerve agent. Supportive care, including [[ventilation]] and [[oxygen therapy]], may also be necessary. | ||
== History and Use == | === History and Use === | ||
The V-series nerve agents were developed | The V-series nerve agents, including VM, were developed during the [[Cold War]] as part of chemical weapons programs. Due to their high toxicity and persistence, these agents are considered weapons of mass destruction and are banned under the [[Chemical Weapons Convention]]. | ||
== Related Pages == | == Related Pages == | ||
* [[Nerve agent]] | * [[Nerve agent]] | ||
* [[Acetylcholinesterase]] | |||
* [[V-series nerve agents]] | |||
* [[Chemical warfare]] | * [[Chemical warfare]] | ||
[[Category:Nerve agents]] | [[Category:Nerve agents]] | ||
[[Category:Chemical warfare]] | |||
[[Category:Chemical warfare | |||
Latest revision as of 11:32, 15 February 2025
VM (Nerve Agent)[edit]
VM is a nerve agent belonging to the V-series nerve agents, which are a group of highly toxic chemical warfare agents. These agents are known for their ability to disrupt the normal functioning of the nervous system by inhibiting the enzyme acetylcholinesterase.
Chemical Structure and Properties[edit]
VM is an organophosphorus compound, characterized by its phosphorus-sulfur bond. The skeletal structure of VM is depicted in the image to the right. Like other V-series agents, VM is a liquid at room temperature and is known for its high boiling point and low volatility, making it a persistent threat in contaminated environments.
Mechanism of Action[edit]
VM, like other nerve agents, exerts its toxic effects by inhibiting the enzyme acetylcholinesterase. This enzyme is crucial for the breakdown of the neurotransmitter acetylcholine in the synaptic cleft. When acetylcholinesterase is inhibited, acetylcholine accumulates, leading to continuous stimulation of muscles, glands, and central nervous system structures. This results in a range of symptoms, including muscle twitching, respiratory failure, and potentially death.
Symptoms of Exposure[edit]
Exposure to VM can lead to a variety of symptoms, depending on the dose and route of exposure. Common symptoms include:
- Miosis (constriction of the pupils)
- Rhinorrhea (runny nose)
- Bronchoconstriction
- Muscle weakness
- Seizures
- Coma
Treatment[edit]
The primary treatment for VM exposure involves the administration of atropine and pralidoxime. Atropine works by blocking the effects of acetylcholine at muscarinic receptors, while pralidoxime reactivates acetylcholinesterase by removing the phosphate group attached by the nerve agent. Supportive care, including ventilation and oxygen therapy, may also be necessary.
History and Use[edit]
The V-series nerve agents, including VM, were developed during the Cold War as part of chemical weapons programs. Due to their high toxicity and persistence, these agents are considered weapons of mass destruction and are banned under the Chemical Weapons Convention.
